Hematuria in patients with IgA nephropathy after vaccine for SARS-CoV-2
Description
No abstract
PubMed COVID-19 Clinical Care
441 - 450 of 1633 results found
Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial
Description
CONCLUSIONS AND RELEVANCE: Among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of COVID-19 symptoms.
How long elective surgery should be delayed from COVID-19 infection in pediatric patients?
Description
No abstract
How mutual aid proliferation developed solidarity and sense of collective responsibility in the early months of COVID-19
Description
Although mutual aid organizing is a social movement practice long sustained by queer/trans people, immigrants, people of color, and disability communities, among other communities pushed to the margins of society, with the emergence of the COVID-19
Humoral response against spike protein enhanced by fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects
Description
Antibody obtained by the coronavirus disease-19 (COVID-19) mRNA vaccine declines over time, and additional vaccinations are offered. It is not clear how repeated vaccination affects humoral immunity in uninfected individuals. We analyzed
Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China
Description
Following the national dynamic zero-COVID strategy adjustment, the utilization of broad-spectrum nasal neutralizing antibodies may offer alternative approach to controlling the outbreak of Omicron variants between late 2022 and early 2023 in China
Hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
Description
No abstract
Humoral and cellular immunity against different SARS-CoV-2 variants in patients with chronic kidney disease
Description
Chronic kidney disease (CKD) patients are at higher risk of severe COVID-19. Humoral and cellular immunity from prior infection or vaccination are important for protection, but the neutralizing antibody (nAb) response against SARS-CoV-2 variants is
Health surveillance for SARS-CoV-2: infection spread and vaccination coverage in the schools of Modena province, Italy
Description
CONCLUSION: Our results highlight the differential spread of the infection within various educational settings and that the vaccination, available in the study period for the population aged ≥12, have mitigated SARS-CoV-2 spread in high and middle